Mars Petcare is launching a new Science & Diagnostics division designed to build on the business’ heritage in science and predictive diagnostics.
Heading up the new division as president is Nefertiti Greene, who joins Mars Petcare from Johnson & Johnson where she served as head of enterprise strategy and chief of staff to the chief executive.
She has acquired almost 30 years of industry experience spanning general management, commercial operations, pre-clinical and clinical research across both the pharmaceutical and medical technology sectors.
Reporting to Loic Moutault, president of Mars Petcare, Greene will oversee the diagnostics business and lead science across Mars Petcare, including the Waltham Petcare Science Institute.
Greene said: “I am excited to join the Mars Petcare leadership team and look forward to using my experience in the healthcare industry to help build on the successes in diagnostics and science at Mars Petcare. As a pet owner I’m looking forward to helping further the reach and impact of diagnostics and science for pets around the world.”
Moutault added: “Nefertiti will play an integral role in the continued growth of our diagnostics business and accelerate the impact of our science.
“We’re very proud of our diagnostics business, which has a central role in the broader Mars Petcare ecosystem as an important way we deliver on our purpose, and we recognize that shifting from curative to preventative veterinary care depends on being able to accurately predict and diagnose disease in pets.”
